Author Question: Cells found in fluids can be reactive mesothelial cells or malignant cells. Which features are found ... (Read 83 times)

Kthamas

  • Hero Member
  • *****
  • Posts: 546
Cells found in fluids can be reactive mesothelial cells or malignant cells. Which features are found in reactive cells but not in malignant cells?
 
  a. Smooth nuclear membranes
  b. Chromatin unevenly distributed
  c. Nucleoli prominent and frequently multiply
  d. Nuclear molding

Question 2

List common morphologic changes associated with cytocentrifugation.
 
  What will be an ideal response?



Anna

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Correct Answer: A

Answer to Question 2

Answer:
 Neutrophils appear hypersegmented.
 Necrotic/pyknotic neutrophils can be mistaken for nRBCs.
 Lymphocytes appear larger than in PB smears.
 Cytoplasmic projections are commonly seen in lymphocytes.
 Lymphocytes appear reactive.
 Monocytes/macrophages are more readily seen with ingested particles.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library